Caution Is Needed When Reporting or Pooling the Prevalence of Venous Thromboembolism in Critically Ill Coronavirus Disease 2019 Patients

Crit Care Med. 2021 Jan 1;49(1):e114-e115. doi: 10.1097/CCM.0000000000004693.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants
  • COVID-19*
  • Critical Illness
  • Humans
  • Incidence
  • Prevalence
  • SARS-CoV-2
  • Venous Thromboembolism*

Substances

  • Anticoagulants